PMID: 15232467Jul 3, 2004Paper

Review of immunosuppressive drug therapy in uveitis

Current Opinion in Ophthalmology
James P Dunn

Abstract

Uveitis is an important cause of functional visual loss and blindness in the developed world. Immunosuppressive drugs may be required to treat severe noninfectious uveitis successfully, but the efficacy and safety of such treatments are often limited by the small numbers of patients enrolled in clinical trials or studied retrospectively, the absence of control participants, and the variable natural course of some types of uveitis. This review was undertaken to highlight recent clinical advances in the treatment of severe noninfectious uveitis. A literature search emphasizing the research published since 2001 was undertaken. The role of previously available immunosuppressives such as antimetabolites, calcineurin inhibitors, and alkylating agents continues to develop. In recent years, more specific drugs, collectively known as biologics, have been used in the treatment of uveitis. A persistent limitation of the published literature remains the general lack of randomized, controlled clinical trials. The long-term risks of most immunosuppressive drugs and the risk of relapse after discontinuation of therapy are also not well established. Tumor necrosis factor-alpha antagonists are promising but extremely expensive, and they may be ...Continue Reading

References

Sep 1, 1996·The British Journal of Ophthalmology·M S Suttorp-Schulten, A Rothova
Jan 26, 1999·Ophthalmology·S DevG J Jaffe
Mar 13, 1999·Annals of Internal Medicine·L W MorelandM E Weinblatt
Feb 24, 2000·The British Journal of Ophthalmology·D J KilmartinJ V Forrester
Jan 6, 2001·Current Opinion in Ophthalmology·M D Becker, J T Rosenbaum
Mar 23, 2001·Ocular Immunology and Inflammation·B WechslerP LeHoang
Mar 23, 2001·Ocular Immunology and Inflammation·S BomS Lightman
Jun 22, 2001·Klinische Monatsblätter für Augenheilkunde·F VonmoosI O Haefliger
Oct 5, 2001·Ophthalmic Research·M Santos LacombaM Omar
Nov 22, 2001·Lancet·S Muñoz-FernándezE Martín-Mola
Dec 12, 2001·Survey of Ophthalmology·S R BoydS Lightman
Feb 5, 2002·Ophthalmology·Shawkat Shafik MichelC Stephen Foster
Apr 6, 2002·Ocular Immunology and Inflammation·B A MudunM O Arslan
May 3, 2002·The New England Journal of Medicine·Jennifer D GormanJohn C Davis
Aug 3, 2002·Ophthalmology·Esen Karamursel AkpekC Stephen Foster
Nov 21, 2002·Retina·Nancy J ChristmasJames C Folk
Jan 24, 2003·Documenta Ophthalmologica. Advances in Ophthalmology·Pinar Cakar OzdalEsin Firat
Feb 18, 2003·The American Journal of the Medical Sciences·Andreas M Reimold
Apr 12, 2003·Ophthalmology·George N PapaliodisC Stephen Foster
Apr 16, 2003·Archives of Ophthalmology·C Stephen FosterCindy M Vredeveld
Apr 26, 2003·Investigative Ophthalmology & Visual Science·Kan KoizumiAntonia M Joussen
Jun 6, 2003·American Journal of Ophthalmology·Gary N Holland, E Richard Stiehm
Jun 6, 2003·American Journal of Ophthalmology·Ross E PettyJames T Rosenbaum
Jul 18, 2003·Ophthalmology·Annie JosephRichard J Powell
Sep 23, 2003·Survey of Ophthalmology·Kaisu KotaniemiKimmo Aho
Oct 9, 2003·Ocular Immunology and Inflammation·Hidetoshi Kawashima
Oct 9, 2003·Ocular Immunology and Inflammation·Audrey Kaplan-MessasRon Neumann
Nov 8, 2003·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sofia AndroudiC Stephen Foster
Nov 15, 2003·Current Opinion in Ophthalmology·C Stephen Foster
Dec 4, 2003·Clinical & Experimental Ophthalmology·Chun H LauSusan Lightman
Dec 4, 2003·American Journal of Ophthalmology·Ilknur Tugal-Tutkun, Meri Urgancioglu
Jan 9, 2004·Ophthalmology·Ahmad M Mansour
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Mar 5, 2004·Annals of Internal Medicine·P P SfikakisN Markomichelakis
Mar 10, 2004·Current Medical Research and Opinion·Verónica Pérez-GuijoEduardo Collantes-Estévez

❮ Previous
Next ❯

Citations

Jul 16, 2010·The Journal of Biological Chemistry·Fuat C YagciIhsan Gursel
May 22, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jae Pil ShinSi Yeol Kim
Jul 31, 2007·Experimental Eye Research·Karen M SijssensJoke H de Boer
Sep 13, 2008·Acta Ophthalmologica·Jelka G OrsoniIsabella Pellistri
Jul 21, 2015·PloS One·Travis J A CraddockGordon Broderick
Nov 22, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·UNKNOWN Deutsche Ophthalmologische Gesellschaft, UNKNOWN Berufsverband der Augenärzte Deutschlands e. V.
Apr 17, 2007·Current Opinion in Ophthalmology·Fraser R Imrie, Andrew D Dick
Jan 5, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Hafezi-MoghadamE S Gragoudas
Aug 3, 2018·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Melissa Meyer Zu HoersteArnd Heiligenhaus
Apr 17, 2008·Molecular Pharmacology·Rodrigo MedeirosJoão Batista Calixto
Mar 19, 2009·Ocular Immunology and Inflammation·Wasna SirirungsiAniki Rothova
Nov 29, 2007·The Nurse Practitioner·Leorey N Saligan, Grace Levy-Clarke
Jan 21, 2021·Frontiers in Immunology·Denis WakefieldPeter McCluskey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.